Hyperbaric Oxygen Therapy in Liver Diseases
Posted on Monday, July 30th, 2018
There have been numerous reports, medical studies, and clinical data to support the use of hyperbaric oxygen therapy (HBOT) for a vast number of liver diseases; namely, acute liver injury, nonalcoholic steatohepatitis, liver transplantation, fibrosis and cancer, especially for hepatic artery thrombosis.
Review of the current literature tell us that HBOT can have a powerful effect on promoting liver regeneration. In terms of liver diseases, it seems that the key physiological benefits of HBOT are in its antioxidant and anti-inflammatory role, helping to provide protection for damaged liver tissue.
The combination of extra protection (though antioxidant and anti-inflammatory support) and enhanced regeneration, make HBOT a potential valuable tool for many liver diseases.
The authors of this study take a more in-depth analysis of HBOT’s role within these disease while also citing relevant studies
Read more about the study here…
Filed under: Hyperbaric Oxygen Therapy (HBOT)